Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Systems Art Holdings Limited was a British Virgin Islands-based holding company that historically held assets related to the beverage and media sectors, which were later transitioned into the healthcare and life sciences space through various corporate restructurings. In 2010, the company was involved in a significant asset sale to Dragon Polymers (formerly Blue Gold Beverages), an entity that eventually pivoted toward heart health and other medical interests. While the company itself is no longer an active participant in the biotech industry, its historical asset transfers played a role in the formation of early-stage healthcare ventures. It is primarily recognized in financial filings as a predecessor or asset-holding entity for companies that later pursued life science initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Systems Art Holdings.